Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,151,216 papers from all fields of science
Search
Sign In
Create Free Account
Oncotype DX Breast Cancer Assay
Known as:
Oncotype DX
A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making.
N. Bhutiani
,
Michael E. Egger
,
N. Ajkay
,
C. Scoggins
,
Robert C. G. Martin
,
K. McMasters
Journal of the American College of Surgeons
2018
Corpus ID: 4323120
2017
2017
The value of algorithms predicting the Oncotype DX recurrence score should not be underestimated!
B. Turner
,
P. Tang
,
D. Hicks
Breast Cancer Research and Treatment
2017
Corpus ID: 22118011
Review
2016
Review
2016
Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.
C. Rutter
,
Xiaopan Yao
,
+7 authors
S. Evans
Clinical Breast Cancer
2016
Corpus ID: 22458539
2016
2016
Breast cancer specific survival in patients with node-positive hormone receptor positive invasive breast cancer and Oncotype DX recurrence score results in the SEER database.
Megan C. Roberts
,
V. Petkov
,
+4 authors
Lynne Penberthy
2016
Corpus ID: 58142883
6575Background: The 21-tumor gene expression assay has been shown to predict breast cancer recurrence and adjuvant chemotherapy…
Expand
2016
2016
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
Su Hyun Lee
,
Seunggyun Ha
,
+9 authors
G. Cheon
European Journal of Nuclear Medicine and…
2016
Corpus ID: 8350102
PurposeOncotype DX, a 21-gene expression assay, provides a recurrence score (RS) which predicts prognosis and the benefit from…
Expand
2015
2015
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
Megan C. Roberts
,
M. Weinberger
,
+5 authors
S. Wheeler
Breast Cancer Research and Treatment
2015
Corpus ID: 11063392
It is unknown whether racial differences exist in adjuvant chemotherapy initiation among women with similar oncotype DX (ODX…
Expand
Review
2015
Review
2015
Menopausal status does not predict Oncotype DX recurrence score.
D. Carr
,
N. Vera
,
+5 authors
C. Laronga
Journal of Surgical Research
2015
Corpus ID: 42817489
Review
2014
Review
2014
Oncotype Dx Results in Multiple Primary Breast Cancers
Michael Toole
,
K. Kidwell
,
C. V. Van Poznak
Breast cancer : basic and clinical research
2014
Corpus ID: 465286
Purpose To determine whether multiple primary breast cancers have similar genetic profiles, specifically Oncotype Dx Recurrence…
Expand
2014
2014
The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea
M. Lee
,
W. Han
,
+7 authors
E. Lee
Cancer research and treatment : official journal…
2014
Corpus ID: 662471
Purpose The 21-gene (Oncotype DX) recurrence score (RS) assay is useful in predicting the benefits of adjuvant chemotherapy for…
Expand
Review
2007
Review
2007
How well do standard prognostic criteria predict oncotype DX (ODX) scores
A. Kamal
,
C. Loprinzi
,
+8 authors
M. Goetz
2007
Corpus ID: 74095660
576 Background: In node-negative, ER + breast cancer, gene expression profiling can identify level of risk and, in the case of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE